Literature DB >> 3103282

Monoclonal anti-IL-2 receptor antibody in primate renal transplantation.

M E Shapiro, R L Kirkman, M H Reed, J D Puskas, G Mazoujian, N L Letvin, C B Carpenter, E L Milford, T A Waldmann, T B Strom.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3103282

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  6 in total

Review 1.  Immunotherapy through the IL-2 receptor.

Authors:  H A Verheul; M Verveld; E S Bos
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

2.  Interleukin 2-diphtheria toxin fusion protein can abolish cell-mediated immunity in vivo.

Authors:  V E Kelley; P Bacha; O Pankewycz; J C Nichols; J R Murphy; T B Strom
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

3.  Cytotoxic activity of an interleukin 2-Pseudomonas exotoxin chimeric protein produced in Escherichia coli.

Authors:  H Lorberboum-Galski; D FitzGerald; V Chaudhary; S Adhya; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

4.  Blockade of the interleukin-2 receptor by anti-Tac antibody inhibits the generation of antigen-nonspecific suppressor T cells in vitro.

Authors:  T Oh-Ishi; C K Goldman; J Misiti; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

5.  Cardiac allograft survival in mice treated with IL-2-PE40.

Authors:  H Lorberboum-Galski; L V Barrett; R L Kirkman; M Ogata; M C Willingham; D J FitzGerald; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 12.779

6.  Chimeric cytotoxin IL2-PE40 delays and mitigates adjuvant-induced arthritis in rats.

Authors:  J P Case; H Lorberboum-Galski; R Lafyatis; D FitzGerald; R L Wilder; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 12.779
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.